LULU vs ORMP · P/E 17, rev $10.59B vs rev $1.3M
Lululemon Athletica Inc. (LULU) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Lululemon Athletica Inc. (LULU) is a apparel retail company listed on US. It is led by Calvin McDonald.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported LULU revenue for 2025-02-02 was $10.59B. Net income was $1.81B. Revenue was up 10.1% from 2024-01-28 to 2025-02-02. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
LULU currently screens at market cap $29.68B and trailing P/E 16.8. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the LULU and ORMP stock pages for the full models.
Not investment advice.